Austrian company wins damages over blood cancer treatmentBesremi is administered by injection (Credit: Shutterstock/Vershinin89)Besremi is administered by injection (Credit: Shutterstock/Vershinin89)An Austrian pharmaceutical company says it has won a €96 million ICC award against its Taiwanese partner in a long-running dispute over a blood cancer treatment.